Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

In vitro anticancer evaluation of platinum(II/IV) complexes with diisoamyl ester of (S,S)-ethylenediamine-N,N'-di-2-propanoic acid.

Zmejkovski BB, Pantelić N, Filipović L, Aranđelović S, Radulović S, Sabo TJ, Kaluđerović GN.

Anticancer Agents Med Chem. 2016 Dec 7. [Epub ahead of print]

PMID:
27928952
2.

Evaluation of functionalized mesoporous silica SBA-15 as a carrier system for Ph3Sn(CH2)3OH against the A2780 ovarian carcinoma cell line.

Bensing C, Mojić M, Gómez-Ruiz S, Carralero S, Dojčinović B, Maksimović-Ivanić D, Mijatović S, Kaluđerović GN.

Dalton Trans. 2016 Dec 21;45(47):18984-18993.

PMID:
27847952
3.

Anionic chlorido(triphenyl)tin(IV) bearing N-phthaloylglycinato or 1,2,4-benzenetricarboxylato 1,2-anhydride ligands: potential cytotoxic and apoptosis-inducing agents against several types of cancer.

Hübner D, Kaluđerović MR, Gómez-Ruiz S, Kaluđerović GN.

Chem Biol Drug Des. 2016 Oct 17. doi: 10.1111/cbdd.12885. [Epub ahead of print]

PMID:
27748051
4.

Versatile antitumor potential of isoxanthohumol: Enhancement of paclitaxel activity in vivo.

Krajnović T, Kaluđerović GN, Wessjohann LA, Mijatović S, Maksimović-Ivanić D.

Pharmacol Res. 2016 Mar;105:62-73. doi: 10.1016/j.phrs.2016.01.011.

PMID:
26784390
5.

Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes.

Ludwig G, Mojić M, Bulatović M, Mijatović S, Maksimović-Ivanić D, Steinborn D, Kaluđerović GN.

Anticancer Agents Med Chem. 2016;16(11):1455-1460.

PMID:
26510901
6.

Ruthenium(II) p-cymene complex bearing 2,2'-dipyridylamine targets caspase 3 deficient MCF-7 breast cancer cells without disruption of antitumor immune response.

Kaluđerović GN, Krajnović T, Momcilovic M, Stosic-Grujicic S, Mijatović S, Maksimović-Ivanić D, Hey-Hawkins E.

J Inorg Biochem. 2015 Dec;153:315-21. doi: 10.1016/j.jinorgbio.2015.09.006.

PMID:
26428537
7.

Improved in vitro antitumor potential of (O,O'-Diisobutyl-ethylenediamine-N,N'-di-3-propionate)tetrachloridoplatinum(IV) complex under normoxic and hypoxic conditions.

Bulatović M, Kaluđerović MR, Mojić M, Zmejkovski BB, Hey-Hawkins E, Vidaković M, Grdović N, Kaluđerović GN, Mijatović S, Maksimović-Ivanić D.

Eur J Pharmacol. 2015 Aug 5;760:136-44. doi: 10.1016/j.ejphar.2015.04.012.

PMID:
25912798
8.

In vitro effects of binuclear (η (6)-p-cymene)ruthenium(II) complex containing bridging bis(nicotinate)-polyethylene glycol ester ligand on differentiation pathways of murine Th lymphocytes activated by T cell mitogen.

Momcilovic M, Eichhorn T, Blazevski J, Schmidt H, Kaluđerović GN, Stosic-Grujicic S.

J Biol Inorg Chem. 2015 Apr;20(3):575-83. doi: 10.1007/s00775-015-1242-x.

PMID:
25827592
9.

In vitro anticancer activity of gold(III) complexes with some esters of (S,S)-ethylenediamine-N,N'-di-2-propanoic acid.

Pantelić N, Stanojković TP, Zmejkovski BB, Sabo TJ, Kaluđerović GN.

Eur J Med Chem. 2015 Jan 27;90:766-74. doi: 10.1016/j.ejmech.2014.12.019.

PMID:
25528331
10.

Correction: Synthesis, cytotoxic and hydrolytic studies of titanium complexes anchored by a tripodal diamine bis(phenolate) ligand.

Barroso S, Coelho AM, Gómez-Ruiz S, Calhorda MJ, Žižak Ž, Kaluđerović GN, Martins AM.

Dalton Trans. 2015 Feb 7;44(5):2497. doi: 10.1039/c4dt90194k.

PMID:
25526919
11.

Synthesis, cytotoxic and hydrolytic studies of titanium complexes anchored by a tripodal diamine bis(phenolate) ligand.

Barroso S, Coelho AM, Gómez-Ruiz S, Calhorda MJ, Zižak Z, Kaluđerović GN, Martins AM.

Dalton Trans. 2014 Dec 14;43(46):17422-33. doi: 10.1039/c4dt00975d. Erratum in: Dalton Trans. 2015 Feb 7;44(5):2497. Dalton Trans. 2015 Feb 7;44(5):2497.

PMID:
25338018
12.

Organotin(IV)-loaded mesoporous silica as a biocompatible strategy in cancer treatment.

Bulatović MZ, Maksimović-Ivanić D, Bensing C, Gómez-Ruiz S, Steinborn D, Schmidt H, Mojić M, Korać A, Golić I, Pérez-Quintanilla D, Momčilović M, Mijatović S, Kaluđerović GN.

Angew Chem Int Ed Engl. 2014 Jun 2;53(23):5982-7. doi: 10.1002/anie.201400763.

PMID:
24828572
13.

Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands.

Ludwig G, Ranđelović I, Maksimović-Ivanić D, Mijatović S, Bulatović MZ, Miljković D, Korb M, Lang H, Steinborn D, Kaluđerović GN.

ChemMedChem. 2014 Jul;9(7):1586-93. doi: 10.1002/cmdc.201300479.

PMID:
24470190
14.

Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.

Ludwig G, Mijatović S, Ranđelović I, Bulatović M, Miljković D, Maksimović-Ivanić D, Korb M, Lang H, Steinborn D, Kaluđerović GN.

Eur J Med Chem. 2013 Nov;69:216-22. doi: 10.1016/j.ejmech.2013.08.025.

PMID:
24042044
15.

Gold(III) complexes with esters of cyclohexyl-functionalized ethylenediamine-N,N'-diacetate.

Pantelić N, Zmejkovski BB, Trifunović-Macedoljan J, Savić A, Stanković D, Damjanović A, Juranić Z, Kaluđerović GN, Sabo TJ.

J Inorg Biochem. 2013 Nov;128:146-53. doi: 10.1016/j.jinorgbio.2013.08.002.

PMID:
23988849
16.

Solid-phase synthesis of reduced selenocysteine tetrapeptides and their oxidized analogs containing selenenylsulfide eight-membered rings.

Wessjohann LA, Schneider A, Kaluđerović GN, Brandt W.

Mol Divers. 2013 Aug;17(3):537-45. doi: 10.1007/s11030-013-9454-x.

PMID:
23729025
17.

Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro.

Blaževski J, Petković F, Momčilović M, Paschke R, Kaluđerović GN, Mostarica Stojković M, Miljković D.

Acta Pharmacol Sin. 2013 Mar;34(3):424-31. doi: 10.1038/aps.2012.181.

18.

Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents.

Ludwig G, Kaluđerović GN, Rüffer T, Bette M, Korb M, Block M, Paschke R, Lang H, Steinborn D.

Dalton Trans. 2013 Mar 21;42(11):3771-4. doi: 10.1039/c3dt33064h.

PMID:
23340605
19.

Melanoma tumor inhibition by tetrachlorido(O,O'-dibutyl-ethylenediamine-N,N'-di-3-propionate)platinum(IV) complex: in vitro and in vivo investigations.

Maksimović-Ivanić D, Mijatović S, Mirkov I, Stošić-Grujičić S, Miljković D, Sabo TJ, Trajković V, Kaluđerović GN.

Metallomics. 2012 Nov;4(11):1155-9. doi: 10.1039/c2mt20150j.

PMID:
23014886
20.

Metals in medicine.

Kaluđerović GN, Gómez-Ruiz S, Maksimović-Ivanić D, Paschke R, Mijatović S.

Bioinorg Chem Appl. 2012;2012:705907. doi: 10.1155/2012/705907. No abstract available.

Items per page

Supplemental Content

Loading ...
Support Center